Search results
Results from the WOW.Com Content Network
There are two sides of the coin in acute myeloid leukemia prognoses. One side is complete remission. The other is recurrence, when AML comes back: Overall, an estimated 50% to 80% of people with acute myeloid leukemia achieve complete remission after treatment. Complete remission happens more often in children and people under age 60.
The prognosis for acute myeloid leukemia varies depending on age, subtype, and response to treatment. The best survival is in patients under age 20, with a five-year survival rate of 68%. For people 20 and older, the five-year survival rate is 26%.
According to the American Cancer Society (ACS), around 90 percent of people with an AML type known as acute promyelocytic leukemia (APL) will go into remission after “induction” (first round) of...
What is the survival rate for acute myeloid leukemia in the elderly? Less than 1 in 3 people who receive a diagnosis of AML will survive more than 5 years following their diagnosis. Learn...
Prognosis estimates the outcome for acute myeloid leukemia (AML). It depends on many factors including subtype, chromosome changes and your age.
Your level of general health and fitness when you are diagnosed with AML does affect prognosis. If you are generally quite well, then you are more likely to be able to have high-intensity treatment, which gives the best chance of a cure.
AML, also known as acute myelogenous leukemia or acute nonlymphocytic leukemia, is very aggressive. However, with prompt and proper treatment it may be curable. AML is classified into a number of subtypes. These may present with different symptoms and can require different treatments. Common subtypes include:
So the prognosis for people diagnosed with AML today is likely better. In fact, treatment advances have almost doubled the 5-year survival rate for leukemias as a combined group. And new treatments are regularly being developed.
Acute myeloid leukemia survival rate According to ASCO , AML isn’t common, accounting for approximately 1 percent of all cancers. However, for those who are diagnosed with AML, survival rates vary from patient to patient, based primarily on age and the type of AML.
Among this age group, the five-year survival rate is relatively poor, hovering at around 5%. Cure rates among younger adults tend to be better, with anywhere from 25% to 70% achieving complete remission following chemotherapy. Leukemia is a diverse group of cancers that affect both blood-forming tissues and the blood cells themselves.